These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28703277)

  • 1. miRNAs and ovarian cancer: An overview.
    Deb B; Uddin A; Chakraborty S
    J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of miRNA in Ovarian Cancer: an Overview.
    Zhao L; Liang X; Wang L; Zhang X
    Reprod Sci; 2022 Oct; 29(10):2760-2767. PubMed ID: 34973152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA signatures in human ovarian cancer.
    Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM
    Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
    Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
    Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
    Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
    Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
    Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network analysis of microRNAs and their regulation in human ovarian cancer.
    Schmeier S; Schaefer U; Essack M; Bajic VB
    BMC Syst Biol; 2011 Nov; 5():183. PubMed ID: 22050994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
    Davidson B; Tropé CG; Reich R
    Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance.
    Liu M; Zhang H; Li Y; Wang S
    Cancer Biother Radiopharm; 2022 Apr; 37(3):186-198. PubMed ID: 35133881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in ovarian carcinomas.
    Dahiya N; Morin PJ
    Endocr Relat Cancer; 2010 Mar; 17(1):F77-89. PubMed ID: 19903743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-210: A Current Overview.
    Bavelloni A; Ramazzotti G; Poli A; Piazzi M; Focaccia E; Blalock W; Faenza I
    Anticancer Res; 2017 Dec; 37(12):6511-6521. PubMed ID: 29187425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes virus microRNA expression and significance in serous ovarian cancer.
    Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
    PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA Analysis in Epithelial Ovarian Cancer].
    Sommerová L; Ďuríková H; Podhorec J; Hrstka R
    Klin Onkol; 2017; 30(Supplementum1):180-183. PubMed ID: 28471201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of microRNA expression in serous ovarian carcinoma.
    Li Y; Yao L; Liu F; Hong J; Chen L; Zhang B; Zhang W
    Int J Mol Med; 2014 Aug; 34(2):491-8. PubMed ID: 24939816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
    Chen Z; Xiao Z; Zeng S; Yan Z
    Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.
    Retamales-Ortega R; Oróstica L; Vera C; Cuevas P; Hernández A; Hurtado I; Vega M; Romero C
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.